ArticleCancer research2013

Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth.

Sarah S Burns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.